Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Co-Defend is a healthcare technology company focused on developing and commercializing innovative solutions for infection control and personal protection. The company gained prominence during the COVID-19 pandemic for its specialized antimicrobial coatings and personal protective equipment (PPE) designed to reduce the transmission of pathogens. Their product portfolio includes advanced face masks and surface treatments that utilize proprietary technologies to provide enhanced defense against viruses and bacteria. Co-Defend aims to bridge the gap between traditional medical supplies and high-tech antimicrobial solutions for both clinical and consumer environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Co-Defend.